RTEL1-TNFRSF6B | RTEL1-TNFRSF6B readthrough (NMD candidate) | Predicted secreted proteins
| | | | | Tissue enriched |
SP140 | SP140 nuclear body protein | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
TMC8 | Transmembrane channel-like 8 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM156 | Transmembrane protein 156 | Predicted membrane proteins
| | | | | Group enriched |
VIP | Vasoactive intestinal peptide | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
ADCYAP1 | Adenylate cyclase activating polypeptide 1 (pituitary) | Predicted secreted proteins
| | | | | Tissue enhanced |
AMICA1 | Adhesion molecule, interacts with CXADR antigen 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AQP9 | Aquaporin 9 | Predicted membrane proteins
| | | | | Tissue enhanced |
C2orf48 | Chromosome 2 open reading frame 48 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C3AR1 | Complement component 3a receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CASS4 | Cas scaffolding protein family member 4 | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CCL17 | Chemokine (C-C motif) ligand 17 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL22 | Chemokine (C-C motif) ligand 22 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCR1 | Chemokine (C-C motif) receptor 1 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR2 | Chemokine (C-C motif) receptor 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR4 | Chemokine (C-C motif) receptor 4 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CD300E | CD300e molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD300LB | CD300 molecule-like family member b | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD80 | CD80 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHI3L2 | Chitinase 3-like 2 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLEC4A | C-type lectin domain family 4, member A | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4E | C-type lectin domain family 4, member E | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC6A | C-type lectin domain family 6, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC7A | C-type lectin domain family 7, member A | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CRLF2 | Cytokine receptor-like factor 2 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CSF2RB | Colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CSF3 | Colony stimulating factor 3 (granulocyte) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CTD-2370N5.3 | | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTD-3088G3.8 | Protein LOC388210 {ECO:0000313|Ensembl:ENSP00000471908} | Predicted intracellular proteins
| | | | | Tissue enhanced |
CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL10 | Chemokine (C-X-C motif) ligand 10 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL11 | Chemokine (C-X-C motif) ligand 11 | Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL5 | Chemokine (C-X-C motif) ligand 5 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCR1 | Chemokine (C-X-C motif) receptor 1 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
EMR2 | Egf-like module containing, mucin-like, hormone receptor-like 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
EMR3 | Egf-like module containing, mucin-like, hormone receptor-like 3 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) | CD markers FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
FCGR1B | Fc fragment of IgG, high affinity Ib, receptor (CD64) | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | CD markers FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR2 | Free fatty acid receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR3 | Free fatty acid receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FOXP3 | Forkhead box P3 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FPR1 | Formyl peptide receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FPR2 | Formyl peptide receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FYB | FYN binding protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
GAL | Galanin/GMAP prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |